Diseases and disorders particularly that of bowels and digestive process is more common than others and colitis is one such common disease that is experienced by countless people all over the world.

Sanofi SAN-1.79%decrease; red down pointing triangle said two bleeding disorder treatments for both chronic and acute conditions have been approved in China, expanding its hematology offerings in the ...

Two bleeding disorder treatments for both chronic and acute conditions, Qfitlia and Cablivi, have been approved in China. Broadcom Reports Earnings After the Close Today. Analysts Expect Strong ...

Despite the considerable disease burden associated with hereditary hemorrhagic telangiectasia, no therapies are licensed for treatment. In a proof-of-concept, placebo-controlled trial, the ...

Hereditary hemorrhagic telangiectasia (HHT) is the second most common inherited bleeding disorder worldwide, affecting 1 in 3,800 persons. HHT’s hallmark symptom is chronic nosebleeds, which often ...

Hereditary hemorrhagic telangiectasia (HHT) can cause recurrent, severe epistaxis, as well as anemia and reduced quality of life. The disease remains without licensed therapies worldwide. In this ...

Bleeding occurs when trauma damages a blood vessel. When that trauma involves your head—whether the scalp, skull, or brain—it’s considered a head injury. These head injuries range in severity from a ...

Wyoming Valley West football will have a new coach next season and a new PIAA classification. The Spartans were among five District 2 programs — three from the Wyoming Valley Conference — which moved ...

With a $157 million series C funding round, Hemab Therapeutics is looking to infuse innovation into the treatment landscape for rare and underserved bleeding disorders. The oversubscribed series C was ...

Background: Bleeding disorders, including hemophilia, von Willebrand disease (VWD), and immune thrombocytopenia (ITP), pose significant diagnostic and therapeutic challenges due to their heterogeneous ...